Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-13-003879)

Filing Details

Accession Number:: 0001437749-13-003879
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-02 17:10:01
Reporting Period:: 2013-04-01

Filing Date:: 2013-04-02
Accepted Time:: 2013-04-02 17:10:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1003642	Impax Laboratories Inc	IPXL	Pharmaceutical Preparations (2834)	650403311

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1245365	Nigel Fleming	C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-04-01	6,000	$6.55	13,999	No	4	M	Direct
Common Stock	Disposition	2013-04-01	6,000	$15.31	7,999	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-04-01	6,000	$0.00	6,000	$6.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,000		2019-05-20	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
The option became exercisable in three equal annual installments beginning on May 20, 2010, which was the first anniversary of the date on which the option was granted.